Abstract:Overweight or obesity has become a critical health problem in the world. The association of obesity with type 2 diabetes mellitus (T2D) has been recognized for decades, and the major basis for this link is the ability of obesity to engender insulin resistance (IR). Adipose tissue is not only an energy depot but also an active endocrine organ. Furthermore, fat distribution in the body is important for the progress of IR. Many studies show that visceral fat is more important in relation to IR than subcutaneous fat. Circulating free fatty acids (FFAs) derived from adipocytes are elevated in many IR states and have been suggested to be a main underlying mechanism of IR in obesity-associated T2D. However, compelling evidence demonstrates that adipocytokines including several adipocyte-derived cytokines or hormones are also involved in obesity-induced IR. Therefore, we hypothesise that adipocytokines may be a bridge connecting obesity and IR, and abnormal fat depot distribution or visceral fat/subcutaneous fat ratio (V/S ratio) in obesity also could be a primer for IR. When visceral fat accumulates and V/S ratio deteriorates , just like a primer,in visceral obesity it should begin to display unhealthy effect begin to take place in the body. In addition to it, as one of physiological regulation mechanisms of the body, most of the adipocytokines from the visceral fat reduce the visceral fat volume or normalize the V/S ratio. Actually, on the contrary, with serum a change in the serum adipocytokine level and an imbalance of them in the body for a long term, it will become a pathological condition and various kinds of effects may contribute to the development of IR. If confirmed, this hypothesis may lead to the formulation of new pathogenesis and new therapeutic approaches to IR. For example, an effective slimming pill will be assessed in future on the basis of the decrease of V/S and serum adipocytokines level rather than of body weight.

Research progress of adipokines related with obesity

Effect of adiponectin on obesity-linked diseases

Progress in Research of Adipokines and Insulin Resistance

Adipokines in Inflammation, Insulin Resistance and Cardiovascular Disease.

[Research progress in regulation of adiponectin receptors expression].

Sphingosine-1-phosphate and obesity-induced inflammation

Adipokines, Hepatokines and Myokines: Focus on Their Role and Molecular Mechanisms in Adipose Tissue Inflammation

Mechanisms of Inflammatory Responses in Obese Adipose Tissue

Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases

Research advance in autophagy in obesity

Adipocytokines: a bridge connecting obesity and insulin resistance.

Insight into the Effects of Adipose Tissue Inflammation Factors on Mir-378 Expression and the Underlying Mechanism

Adipokines in atopic dermatitis: the link between obesity and atopic dermatitis

Adipose Tissue Inflammation and Metabolic Dysfunction in Obesity.

FFAs and Adipokine-Mediated Regulation of Hsa-Mir-143 Expression in Human Adipocytes

Adipocyte promotes adipose tissue inflammation and insulin resistance by modulating macrophages in obesity

Adipokines: masterminds of metabolic inflammation

Mechanism and Clinical Evidence of Lipocalin‐2 and Adipocyte Fatty Acid‐binding Protein Linking Obesity and Atherosclerosis

New advances of adiponectin in regulating obesity and related metabolic syndromes

Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease

Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression